Company ordered to halt sales of unapproved drugs, reimburse buyers.
D003879:Dermatologic Agents; D017277:Drug Approval; D004348:Drug Labeling; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D009515:New Jersey; D014052:Toluidines; D014990:Xylans
D003879:Dermatologic Agents; D014052:Toluidines; D014990:Xylans; C419427:polysaccharide MGN3; C005947:benefin